Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

por Wang, Shuai, Wu, Chongming, Li, Xin, Zhou, Yue, Zhang, Quanyang, Ma, Fuchao, Wei, Jianhe, Zhang, Xiaopo, Guo, Peng
Publicado 2017

The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

por Li, Juan, Lei, Runhong, Li, Xin, Xiong, Fengxia, Zhang, Quanyang, Zhou, Yue, Yang, Shengmei, Chang, Yanan, Chen, Kui, Gu, Weihong, Wu, Chongming, Xing, Gengmei
Publicado 2018